An International, Multi-centre, Prospective, Non-controlled, Open, Single-group, 8-week Trial in Adolescent Subjects

Completed · Phase 2

Conditions studied: Psoriasis Vulgaris

In brief

An international, multi-centre, prospective, non-controlled, open, single-group, 8-week trial in adolescent subjects (aged 12 to 16 years, 11 months) with scalp and body psoriasis.

Key facts

Study ID
NCT02038569
Run by
LEO Pharma
People needed
125
Starts
2014-01-01
Expected to finish
2018-02-13
Last updated by the study team
2025-03-10

Who can join

Age: 12 and older, up to 17. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.